Glucosodiene: Opening a New Branch of Chemotherapic Sciences Called Toxinutromedicanical-Chemotherapy
Chemotherapy is a widely employed treatment modality in the fight against cancer aiming to eliminate both normal and cancerous cells. However, its non-discriminatory nature leads to severe side effects [1].
Letter to Editor
Chemotherapy is a widely employed treatment modality in the fight against cancer aiming to eliminate both normal and cancerous cells. However, its non-discriminatory nature leads to severe side effects [1].
On the other hand, the treatment involving glucosodiene has shown promising results, particularly after the submission of a manuscript presenting its effectiveness in treating the first human case of triple-negative breast cancer (TNBC) that had metastasized to the bones [2].
The patient achieved complete recovery in less than a month. Research studies proposing and discussing the impact of glucosodiene as a promising theory for cancer treatment have shed light on its ability to modify glucose and endow it with alkaline properties [3, 4]. This modification potentially allows for the destruction or metabolic inhibition of glucose within the tumor, a phenomenon known as the Warburg effect. Despite the ongoing extensive study to document the final chemical structure of glucosodiene [5, 6, 7, 8], this approach and its results may herald a new branch of chemotherapy known as “toxinutromedicanical-chemotherapy.” This field can be defined as a science dedicated to exploring the possibility of modifying cellular nutrition, specifically glucose, and imbuing it with chemical, alkaline, Letter to Editor and therapeutic properties through substitution reactions or by loading therapeutic agents onto glucose. Consequently, this approach achieves direct killing of cancer cells through their metabolic activity and their avidity for glucose. The promising results demonstrated by glucosodiene merit further investigation and study within this emerging field.
Statements and Declarations
The authors declare that there are no conflicts of interest.
References
-
Anderson MK, Matey L (2019) Overview of cancer and cancer treatment. In: Olsen MM, LeFebvre KB, (Eds) et al. Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice. Pittsburgh, PA: Oncology Nursing Society, pp: 25-50.
-
Ahmed A (2023) Targeting the Warburg Effect with Glucosodiene: A Case Report of a 43-year-old Female after Mastectomy of the right breast and axillary clearance with Successful First Case Treatment for Metastatic Triple Negative Breast Cancer (TNBC) of Bone.
-
Akl MM (2023) Targeting Cancerous Tumors through their Metabolic Activity via Glucose Receptors in the Tumor; Known as the Alkaline Glucosodiene Molecules Theory. Clinical and Experimental Cancer Research and Therapeutics 1(1).
-
Akl MM, Abou El, Naga AM (2023) Toxic chemotherapeutic nutrition of cancer cells by alkaline glucosodiene molecules via targeting metabolic of cancerous tumors: a promising theory for cancer treatment. Cancer Adv 6: e23010.
-
Akl MM, Ahmed A (2023) Novel chemical structure discovery named glucosodiene Polymer as an isomer of alkaline glucose compound resulting from the reaction between dextrose and sodium bicarbonate. Research Square.
-
Akl MM (2023) Cancer Advances Editorial Office. Retraction: Toxic chemotherapeutic nutrition of cancer cells by alkaline glucosodiene molecules via targeting metabolic of cancerous tumors: a promising theory for cancer treatment. Cancer Adv 6: e23010.
-
Amr A (2023) The Safety of Glucosodiene on an In-Vitro Biopsy Cell Line Model. Research Square.
-
Akl MM, Ahmed A (2023) Developing the theory of Toxic Chemotherapeutic Nutrition for Cancer Cells: Glucosodiene Polymer Structure, Safety, Efficacy, and Human Outcomes in Targeting Tumors via Glucose Mutation. Research Square.
- The Muculent Bleb-Mucinous Cystic Neoplasm-Hepatobiliary Region
- Insulin Sensitizers as Anti-Aging Agents: Unveiling Synergies with Albumin, GLP-1RA, Klotho Protein, and Metformin in the Quest to Combat Aging
- Reprogramming of GLP-1 Response at Prediabetes for the Prevention of Type 2 Diabetes: The Role of Albumin and GLP-1 Receptor Agonists
- The Mingled Allies-Combined Hepatocellular Carcinoma and Cholangiocarcinoma
- Compilation and Embodiment-Leydig Cell Tumour Testis
- Glucolipotoxicity: A Novel Different Perspective on the Causes of Cancer